Arrivo BioVentures, LLC — Form D
Arrivo BioVentures, LLC of MORRISVILLE, NC, a company, filed a Form D exempt-offering notice with the SEC on 2023-11-29. The offering totals $45.3M, of which $43.2M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2023-11-29
- Form: D
- Accession: 0001674649-23-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $45.3M
- Amount sold: $43.2M
- Remaining: $2.1M
- Investors: 58
- Date of first sale: 2023-11-17
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-498306
Issuer
- Name: Arrivo BioVentures, LLC
- CIK: 0001674649
- Entity type: Limited Liability Company
- Jurisdiction: DELAWARE
- Incorporated: 2016
- Address: 3000 RDU Center Drive, MORRISVILLE, NC, 27560
- Phone: 919-753-7067
Officers, directors & promoters (3)
| Name | Role | Location |
|---|
| Karen E Adams | Executive Officer | Morrisville, NC |
| Stephen E Butts | Executive Officer | Morrisville, NC |
| William N Wofford | Executive Officer | Morrisville, NC |
Other filings by this issuer (1)
More